Addressing "undruggable" oncology targets by delivering whole antibodies inside the tumor and metastatic cells.
LiberaBio is a dynamic biotechnology research company focused on addressing challenging oncology targets. By delivering whole antibodies inside tumor and metastatic cells, LiberaBio is pioneering new approaches to cancer treatment. LiberaBio is dedicated to creating innovative solutions in the fight against cancer through advanced biotechnological methods. The company's commitment to research and development positions it as a key player in the evolving landscape of oncology therapeutics.
Based in Santiago de Compostela, Galicia 15782, ES, with an additional location in Larchmont, New York 10538, US, LiberaBio leverages its proprietary MPN technology to actively target tumor and metastatic cells. This nanotechnology enables the delivery of both small and large molecules to on-surface, transmembrane, or intracellular targets, opening new avenues for therapeutic intervention. LiberaBio's unique approach involves delivering novel antibodies that target intracellular oncoproteins, driving the development of groundbreaking treatments.
LiberaBio's mission is to revolutionize cancer treatment by targeting previously "undruggable" targets. LiberaBio is poised to make significant contributions to the field of oncology. We invite the management of LiberaBio to create a customized and exclusive company showcase and product listing on our platform, further highlighting their innovative work.
LiberaBio es una empresa dinámica de investigación biotecnológica centrada en abordar objetivos oncológicos desafiantes. Al entregar anticuerpos completos dentro de las células tumorales y metastásicas, LiberaBio está siendo pionera en nuevos enfoques para el tratamiento del cáncer. LiberaBio se dedica a la creación de soluciones innovadoras en la lucha contra el cáncer a través de métodos biotecnológicos avanzados. El compromiso de la empresa con la investigación y el desarrollo la posiciona como un actor clave en el panorama en evolución de la terapéutica oncológica.
Con sede en Santiago de Compostela, Galicia 15782, ES, con una ubicación adicional en Larchmont, Nueva York 10538, EE. UU., LiberaBio aprovecha su tecnología MPN patentada para atacar activamente las células tumorales y metastásicas. Esta nanotecnología permite la administración de moléculas pequeñas y grandes a objetivos en la superficie, transmembrana o intracelulares, lo que abre nuevas vías para la intervención terapéutica. El enfoque único de LiberaBio implica la entrega de nuevos anticuerpos dirigidos a oncoproteínas intracelulares, impulsando el desarrollo de tratamientos innovadores.
La misión de LiberaBio es revolucionar el tratamiento del cáncer apuntando a objetivos previamente "no farmacéuticos". LiberaBio está preparada para realizar contribuciones significativas al campo de la oncología. Invitamos a la dirección de LiberaBio a crear una presentación de empresa y un listado de productos personalizados y exclusivos en nuestra plataforma, destacando aún más su innovador trabajo.
Compare LiberaBio with 3 companies in Biotechnology-Research
| Comparison Field |
LiberaBioMain Company |
MundipharmaView Profile |
Arrotex Pharmaceutic...View Profile |
RCG IntelView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1952 | 2023 | |
|
Company Size
|
— | 1,001-5,000 | 201-500 | 11-50 |
|
City
|
Santiago de Compostela, Galicia | Cremorne, Victoria | Camden, Delaware | |
|
Country
|
Australia | |||
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Biotechnology
Oncology
Antibody Delivery
Cancer Treatment
Nanotechnology
Drug Development
MPN Technology
Biosimilars
Oncoproteins
Active targeting
Intracellular
Drug delivery
Nanomedicine
Cytotoxics
Antibodies
|
11 Total
11 Unique
Unique Skills:
diabetes
Global network
Market access
Pain
Partnering
pharma partnering
+5
|
17 Total
17 Unique
Unique Skills:
Analgesics
Antibiotics
Anti-infectives
Cardiovascular
Central nervous system
Community Pharmacy
+11
|
19 Total
19 Unique
Unique Skills:
CNS & others
Commercial / Br/ Launch Strategy
Competitive Intelligence
Due Diligence & Opportunity Assessment
Forecasting & Modeling
Gene & Cell Therapy
+13
|
Other organizations in the same industry
This company is also known as